Understanding Brain Activity in Movement Disorders
This study aims to better understand how certain brain areas (cortex, basal ganglia, thalamus, and cerebellum) are involved in movement disorders like Parkinson's disease, dystonia, and essential tremor. Researchers will record brain electrical activity using non-invasive scalp electrodes or through deep brain stimulation (DBS) devices if you have one that can sense brain activity. These recordings, along with your movement disorder symptoms, will help identify specific brain signals related to these conditions. You might be eligible if you are 18 or older and have a diagnosed movement disorder, but not dementia. The study plans to enroll 100 participants and is ongoing, with brain signal biomarkers measured over 5 years.
- Study design
- This is an interventional study with a planned enrollment of 100 participants. It is not specified if the study is randomized or blinded.
- What's involved
- Recordings will be made from your scalp with a noninvasive electrode, or through your DBS stimulator if you have one. Your prescribed medications and DBS settings may be adjusted within normal clinical limits.
- Compensation
- Not stated in the trial record.
- Follow-up
- Neural signal biomarkers will be measured at 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Neural signal biomarkers5 years
Spatiotemporal patterns of brain neural activity (neural signal biomarkers / neurophysiologic signatures) associated with movement disorders symptoms.